(Q46128074)

English

Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study

scientific article published on 8 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hee Seung Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

Mi-Kyung Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

Hyun Hoon Chung

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

Jae Weon Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

Noh Hyun Park

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

Yong Sang Song

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

Soon Beom Kang

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

language of work or name

0 references

publication date

8 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

113

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

264-269

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

mdr-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Multidrug resistance gene-1 is a useful predictor of Paclitaxel-based chemotherapy for patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Polymorphisms in Genes of Nucleotide and Base Excision Repair: Risk and Prognosis of Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

The C19007T polymorphism of ERCC1 and its correlation with the risk of epithelial ovarian and endometrial cancer in Korean women. A case control study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

The role of glutathione-S-transferase polymorphisms in ovarian cancer survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Glutathione S-transferase P1 Ile105Val polymorphism is associated with haematological toxicity in elderly rectal cancer patients receiving preoperative chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.01.002

7 January 2021

Identifiers

10.1016/J.YGYNO.2009.01.002

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19203783

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46128074&oldid=2093885429"